Oturum Aç

Chapter 25

Insulin and Hypoglycemic Drugs

Glukoz Homeostazı: Kan Şekerinin Düzenlenmesi
Glukoz Homeostazı: Kan Şekerinin Düzenlenmesi
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels ...
Glukoz Homeostazı: Pankreas Adacıkları ve İnsülin Sekresyonu
Glukoz Homeostazı: Pankreas Adacıkları ve İnsülin Sekresyonu
The pancreas comprises highly vascularized and innervated pancreatic islets, encompassing α, β, δ, PP, and ε endocrine cells. Amongst ...
İnsülin: Reseptör ve Sinyal Yolları
İnsülin: Reseptör ve Sinyal Yolları
The insulin receptor belongs to the receptor tyrosine kinase family. It comprises disulfide-linked α/β dimers, forming a transmembrane ...
Diyabet Patofizyolojisi
Diyabet Patofizyolojisi
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The two most common types of diabetes mellitus are type 1 and type 2. ...
Diyabet: Belirtileri, Tanısı ve Komplikasyonları
Diyabet: Belirtileri, Tanısı ve Komplikasyonları
Diabetes can be initially identified based on symptoms. Hyperglycemic patients may present common symptoms, including polyuria, polydipsia, fatigue, and ...
Diyabet: Yönetim ve Farmakoterapi
Diyabet: Yönetim ve Farmakoterapi
The goals of diabetes therapy include glycemic control, alleviating hyperglycemia-related symptoms, and preventing or reducing chronic end-organ ...
İnsülin: Biyosentez, Kimya ve Hazırlama
İnsülin: Biyosentez, Kimya ve Hazırlama
The pancreatic β-cell's endoplasmic reticulum synthesizes preproinsulin comprising a signal peptide, B and A chains, and a C-peptide. The ...
İnsülin Formülasyonları: Türleri ve Dağıtımı
İnsülin Formülasyonları: Türleri ve Dağıtımı
Insulin preparations, based on their duration of action, are categorized as short-acting and long-acting. Short-acting regular insulin forms hexamers, ...
İnsülin: Doz Rejimi ve Yan Etkileri
İnsülin: Doz Rejimi ve Yan Etkileri
Insulin dosage regimens generally include a mixture of analogs given as daily injections. Typically, most patients are prescribed long and short-acting ...
Oral Hipoglisemik Ajanlar: Sülfonilüreler
Oral Hipoglisemik Ajanlar: Sülfonilüreler
Sulfonylureas are a class of insulin secretagogues. They are used as oral hypoglycemic agents for managing Type 2 diabetes. Structurally, these drugs ...
Oral Hipoglisemik Ajanlar: Biguanidler ve Glitazonlar
Oral Hipoglisemik Ajanlar: Biguanidler ve Glitazonlar
Biguanides are insulin sensitizers that enhance glucose uptake, reducing insulin resistance. Unlike sulfonylureas, they do not stimulate insulin ...
Oral Hipoglisemik Ajanlar: Glinidler
Oral Hipoglisemik Ajanlar: Glinidler
Glinides are insulin secretagogues that trigger insulin release from β cells by inhibiting KATP channels and controlling potassium efflux. They share ...
Oral Hipoglisemik Ajanlar: α-Glukozidaz İnhibitörleri
Oral Hipoglisemik Ajanlar: α-Glukozidaz İnhibitörleri
α-glucosidase inhibitors impede intestinal α-glucosidase enzymes, delaying the digestion of starch and disaccharides. This effectively curtails ...
Glukagon Benzeri Reseptör Agonistleri
Glukagon Benzeri Reseptör Agonistleri
Oral glucose intake triggers gut hormones like GLP-1 and GIP called incretins, which stimulate insulin secretion. Both GLPs and glucagon originate from ...
Dipeptidil Peptidaz 4 İnhibitörleri
Dipeptidil Peptidaz 4 İnhibitörleri
Dipeptidyl peptidase 4, or DPP-4 inhibitors, called gliptins inhibit incretin hormone inactivation. These drugs bind to DPP-4,  increasing the levels ...
Hipoglisemi ve Glukagon
Hipoglisemi ve Glukagon
Without prolonged fasting, healthy individuals maintain blood glucose levels >80 mg/dL due to a well-adapted neuroendocrine system. However, ...
JoVE Logo

Gizlilik

Kullanım Şartları

İlkeler

Araştırma

Eğitim

JoVE Hakkında

Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır